Literature DB >> 15284251

Managing accrual in cooperative group clinical trials.

Todd L Demmy1, Joyce M Yasko, Deborah E Collyar, Mira L Katz, Carol L Krasnov, Margaret J Borwhat, Anne Battershell, Stephen L George.   

Abstract

Mesh：

Year:  2004        PMID： 15284251     DOI： 10.1200/JCO.2004.10.073

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Conceptual Model for Accrual to Cancer Clinical Trials.

Authors:  Simon J Craddock Lee; Caitlin C Murphy; Ann M Geiger; David E Gerber; John V Cox; Rasmi Nair; Celette Sugg Skinner
Journal:  J Clin Oncol       Date:  2019-06-05       Impact factor: 44.544

2.  Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.

Authors:  Anneke T Schroen; Gina R Petroni; Hongkun Wang; Monika J Thielen; Daniel Sargent; Jacqueline K Benedetti; Walter M Cronin; Donald L Wickerham; Xiaofei F Wang; Robert Gray; Wendy F Cohn; Craig L Slingluff; Benjamin Djulbegovic
Journal:  Clin Trials       Date:  2011-08-30       Impact factor: 2.486

3.  Influence of clinical communication on patients' decision making on participation in clinical trials.

Authors:  Terrance L Albrecht; Susan S Eggly; Marci E J Gleason; Felicity W K Harper; Tanina S Foster; Amy M Peterson; Heather Orom; Louis A Penner; John C Ruckdeschel
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

4.  Assessing the challenges of multi-scope clinical research sites: an example from NIH HIV/AIDS clinical trials networks.

Authors:  Scott R Rosas; Marie T Cope; Christie Villa; Mahnaz Motevalli; Jill Utech; Jeffrey T Schouten
Journal:  J Eval Clin Pract       Date:  2013-11-13       Impact factor: 2.431
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.